KIR3DL2 expression in cutaneous T-cell lymphomas: expanding the spectrum for KIR3DL2 targeting-Reference-Cited by-同舟云学术

KIR3DL2 expression in cutaneous T-cell lymphomas: expanding the spectrum for KIR3DL2 targeting

Published:2017-12-28 Issue:26 Volume:130 Page:2900-2902
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Battistella Maxime¹²,Leboeuf Christophe²,Ram-Wolff Caroline³⁴,Hurabielle Charlotte³⁴,Bonnafous Cécile⁵,Sicard Hélène⁵,Bensussan Armand⁴,Bagot Martine³⁴,Janin Anne¹²

Affiliation:

1. Pathology Department, Assistance Publique Hôpitaux de Paris Hôpital Saint Louis, Paris, France;

2. INSERM U1165, Université Paris 7, Paris, France;

3. Dermatology Department, Assistance Publique Hôpitaux de Paris Hôpital Saint Louis, Paris, France;

4. INSERM U976, Université Paris 7, Paris, France; and

5. Innate Pharma, Marseille-Luminy, France

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/130/26/2900/1403557/blood792382.pdf

Reference12 articles.

1. Usefulness of KIR3DL2 to diagnose, follow-up and manage the treatment of Sézary syndrome patients;Hurabielle;Clin Cancer Res,2017

2. Absolute CD3+ CD158k+ lymphocyte count is reliable and more sensitive than cytomorphology to evaluate blood tumour burden in Sézary syndrome;Bouaziz;Br J Dermatol,2010

3. Use of PLS3, Twist, CD158k/KIR3DL2, and NKp46 gene expression combination for reliable Sézary syndrome diagnosis;Michel;Blood,2013

4. CD158K/KIR3DL2 transcript detection in lesional skin of patients with erythroderma is a tool for the diagnosis of Sézary syndrome;Ortonne;J Invest Dermatol,2008

5. CD158k/KIR3DL2 and NKp46 are frequently expressed in transformed mycosis fungoides;Ortonne;Exp Dermatol,2012

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting TAG-72 in cutaneous T cell lymphoma;Heliyon;2024-09

2. Single-cell RNA sequencing comparison of CD4+, CD8+ and T-cell receptor γδ+ cutaneous T-cell lymphomas reveals subset-specific molecular phenotypes;British Journal of Dermatology;2024-08-12

3. Primary cutaneous acral CD8+ T-cell lymphoproliferative disorder: a benign or malignant process?;British Journal of Dermatology;2024-07-26

4. Delving into the Metabolism of Sézary Cells: A Brief Review;Genes;2024-05-17

5. Immunobiology and treatment of cutaneous T-cell lymphoma;Expert Review of Clinical Immunology;2024-03-07